Patients with CSU have a higher burden than patients with CIndU, including on quality of life, economic effect, and knowledge about treatment.

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Why and how does exercise reduce cancer risk, and what should everyone know about incorporating exercise programs in their lives?

Post-COVID data show that circulatory claims have increased by nearly 60%, while neoplasms remain the leading source of ...

When it comes to weight loss, providers and patients argue that GLP-1 medications are not a one-for-one swap and that volatile insurance coverage contradicts the science and experience of people ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Patients with chronic respiratory failure who meet usage criteria will have more access to respiratory assist devices.

Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...

A recent White House executive order could make it harder for millions of Americans to access their lifesaving medications.

A quarter of people seeking care for symptoms of chronic respiratory diseases in Kenya may incur 'catastrophic' health costs, new research published in The Lancet Global Health has found.

Nearly 130 million Americans are estimated to have at least one form of chronic disease.

Virtual consultations are reshaping chronic disease care—offering flexibility, real-time monitoring, and better outcomes for millions of patients.